Skip To Main Content
Timothy Barrett on Muck Rack

Timothy Barrett

As seen in: The New England Journal of Medicine, Stem Cell Reports, Burlington Free Press, Paediatrics and Child Health
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Timothy

Contact Timothy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Autophagy is required for the development and functionality of lacrimal gland-like organoids

|
By Gamze Kocak, Miriam E. Korsgen, Congxin Sun, Merve Ceylan, Malgorzata Zatyka, Elena Seranova, Animesh Acharjee, Timothy Barrett, Adil Mardinoglu, Sinan Guven, Sovan Sarkar, Leticia F. Amores, Asmaa Ghazwani, Merve Kandirici, Bayram Yuksel
| Stem Cell Reports Verified
Keywords autophagy cell death differentiation development hESC organoid SEAM lacrimal gland PAX6 NMN Introduction The lacrimal gland (LG) is an exocrine gland responsible for producing the aqueous component of tear film, which is essential for maintaining ocular surface moisture and homeostasis. Proper functioning of LG relies on the coordinated organization of acinar, ductal, and myoepithelial cells (Zoukhri, 2010).
Open in Who Shared Issue with article?

Glucagon-like peptide-1 (GLP-1) receptor agonists: applications in childhood diabetes and obesity

|
By Kun Hu, Timothy Barrett
| Paediatrics and Child Health Verified
1Kun Hu BmedSc MBChB MCPCH Clinical Research Fellow, Department of Cancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK and Department of Paediatric Endocrinology and Diabetes, Birmingham Women's and Children's Hospital.
Open in Who Shared Issue with article?

Once-Weekly Semaglutide in Adolescents with Obesity

|
By Daniel Weghuber, Timothy Barrett, Dan Hesse, Aaron Kelly
| The New England Journal of Medicine Verified
Article Figures/Media Metrics Related Articles Abstract Background A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug in adolescents has been lacking.
Open in Who Shared Issue with article?
See all 4 articles